Life ExpectancySurvival RateLife TablesQuality of LifeSurvival AnalysisMortalityCell SurvivalTreatment OutcomeDisease-Free SurvivalCause of DeathQuality-Adjusted Life YearsFollow-Up StudiesAge FactorsCost-Benefit AnalysisLongevityRetrospective StudiesSurvivalMarkov ChainsTime FactorsPrognosisKaplan-Meier EstimateSex FactorsGross Domestic ProductDecision Support TechniquesGraft SurvivalRisk FactorsUnited StatesSex DistributionNeoplasm StagingCohort StudiesAge DistributionProportional Hazards ModelsInfant, NewbornDisabled PersonsSet (Psychology)Combined Modality TherapyPolitical SystemsHealth StatusDeveloped CountriesProspective StudiesHealth Status IndicatorsHealth Status DisparitiesActuarial AnalysisNeoplasm Recurrence, LocalRisk AssessmentAntineoplastic Combined Chemotherapy ProtocolsVital StatisticsSocioeconomic FactorsValue of LifeRegistriesDemocracyNeoplasmsMultivariate AnalysisJapanEconomicsLung NeoplasmsEuropeQuestionnairesEurope, EasternHousing for the ElderlyBreast NeoplasmsLiver NeoplasmsCensusesAsia, CentralDisease ProgressionLifeModels, EconomicSmokingHealth Care CostsIncidencePalliative CareChemotherapy, AdjuvantAgingPatient SelectionIncomeSocial ClassEducational StatusAntineoplastic AgentsHealth SurveysMass ScreeningForecastingAdenocarcinomaCommonwealth of Independent StatesNetherlandsProbabilityAlcohol DrinkingModels, StatisticalInfant MortalityPostoperative ComplicationsMortality, PrematureRecurrenceActivities of Daily LivingChronic DiseaseMorbidityPredictive Value of TestsRegression AnalysisCardiovascular DiseasesCarcinoma, HepatocellularWorld HealthGreat Britain